Dr. Frank Bedu-Addo, Ph.D. - CEO, PDS Biotech - Transforming How The Immune System Fights Disease

Progress, Potential, and Possibilities Podcast / Show

Send us a text

Dr. Frank Bedu-Addo, Ph.D. has served as a director, president and CEO of PDS Biotech ( https://pdsbiotech.com/ ) since its inception in 2005, a biotech company focused on transforming how the immune system targets and fights disease by developing a new generation of targeted cancer treatments.
Dr. Bedu-Addo is a veteran biotech executive with experience successfully starting and growing biotechnology organizations. He has been responsible for the development and implementation of both operational and drug development strategies, supervising and managing both large organizations and emerging biotechnology companies.
Dr. Bedu-Addo was a founding and senior executive at KBI BioPharma, Inc. As Vice President of Drug Development, he oversaw all business and drug development operations. Before his tenure at KBI, he successfully started and managed Cardinal Health’s East Coast biotechnology drug development operations.
Prior to Cardinal Health, Dr. Bedu-Addo was an Associate Director at Akzo-Nobel, Senior Scientist at Elan (The Liposome Co.), and Principal Scientist at Schering-Plough. In these positions, he contributed to the development of numerous drugs, including antiviral and anticancer products.
Dr. Bedu-Addo obtained his M.S. in Chemical Engineering and Ph.D. in Pharmaceutics from the University of Pittsburgh.
#FrankBeduAddo #PDSBiotech #ChemicalEngineering #Pharmaceutics #Liposomes #EnantiospecificCationicLipidNanoparticles #Versamune #IL12 #AntibodyDrugConjugate #HumanPapillomavirus #HPV #HeadAndNeckCancer #UniversalFluVaccines #TumorAssociatedProteins #Oncology #ProgressionFreeSurvival #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research

Support the show